Savior Lifetec Corporation
TWO: 4167.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chih-Fang Chen
- Employees
- 384
- Headquarters
- Miaoli, Taiwan
- IPO year
- 2012
- Market cap
- NT$5.8B
- Website
- https://www.saviorlifetec.com.tw
Loading 4167…
Loading profile data…Frequently asked questions about 4167
What does Savior Lifetec Corporation (4167.TWO) do?
Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertape...
Where does 4167.TWO trade?
Savior Lifetec Corporation (4167.TWO) trades on the Taipei Exchange.
What sector is 4167.TWO in?
Savior Lifetec Corporation (4167.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Savior Lifetec Corporation?
Chih-Fang Chen is the chief executive officer of Savior Lifetec Corporation (4167.TWO).
Where is Savior Lifetec Corporation headquartered?
Savior Lifetec Corporation is headquartered in Taiwan.
Does 4167.TWO pay a dividend?
Yes — Savior Lifetec Corporation (4167.TWO) paid a trailing twelve-month dividend of TWD 0.41 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4167.TWO go public?
Savior Lifetec Corporation (4167.TWO) completed its initial public offering in 2012.